CIAO DATE: 12/05
Junk Science Reigns
On the Issue
September 2005
John E. Calfee
The American Enterprise Institute for Public Policy Research
Abstract
The recent verdict in a case involving the pain reliever Vioxx demonstrates how junk science can corrupt drug litigation. Reporting on the trial and the broader controversy over the drug exacerbates the problem and discourages patients from taking reasonable risks to relieve pain.